Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous rhIGF-1/rhIGFBP-3 infusion to maintain physiological IGF-1 levels in premature infants for prevention of retinopathy of prematurity
2007-007872-40Phase 2Completed
- Sponsor
- Premacure
- Start
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Premiplex in retinopathy of prematurity (ROP) (2 arms), sponsored by Premacure. Primary endpoint: Severity of retinopathy of prematurity. Started Sep 2008; status: completed.
02
Drugs
Premiplex
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on 2007-007872-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007872-40.